Giorgio B Boncoraglio Selected Research

Cholesterol

1/2019	Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.
1/2006	An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio B Boncoraglio Research Topics

Disease

12	Stroke (Strokes) 08/2021 - 01/2006
7	Ischemic Stroke 08/2021 - 01/2013
3	Transient Ischemic Attack 08/2021 - 01/2019
3	Myocardial Infarction 08/2021 - 01/2006
2	Hypertension (High Blood Pressure) 01/2019 - 01/2006
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Embolic Stroke 01/2019
1	Myalgia 01/2019
1	Rhabdomyolysis 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2016
1	Gout 02/2016
1	Genetic Risk Score 02/2016
1	Coronary Disease (Coronary Heart Disease) 02/2016
1	Heart Failure 02/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2016
1	Cerebral Small Vessel Diseases 03/2015
1	Inflammation (Inflammations) 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Vasculitis (Vasculitides) 01/2015
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2015
1	Carotid Stenosis (Carotid Artery Stenosis) 07/2014
1	Siderosis 01/2012
1	Hemorrhage 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2009

Drug/Important Bio-Agent (IBA)

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2021 - 04/2009
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	CholesterolIBA 01/2019 - 01/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2006
1	TicagrelorIBA 08/2021
1	Clopidogrel (Plavix)FDA Link 08/2021
1	Ticlopidine (Ticlid)FDA LinkGeneric 08/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2021
1	Cilostazol (Pletal)FDA LinkGeneric 08/2021
1	ORALIT (ORS)IBA 08/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	MagnesiumIBA 01/2019
1	theasinensin AIBA 01/2019
1	CalciumIBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019
1	Phosphates (Orthophosphate)IBA 11/2016
1	salicylhydroxamic acid (SHAM)IBA 11/2016
1	Uric Acid (Urate)IBA 02/2016
1	Serine Proteases (Serine Protease)IBA 02/2016
1	CollagenIBA 03/2015
1	AutoantibodiesIBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Messenger RNA (mRNA)IBA 07/2014
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2013
1	FibrinIBA 01/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2012
1	HemosiderinIBA 01/2012
1	Ferritins (Ferritin)IBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2006
1	Plasminogen Activator Inhibitor 1IBA 01/2006
1	Oral ContraceptivesIBA 01/2006

Therapy/Procedure

3	Secondary Prevention 08/2021 - 01/2019
3	Therapeutics 01/2018 - 01/2006
2	Transplantation 01/2017 - 01/2010
1	Intravenous Infusions 01/2017
1	Immunotherapy 01/2015
1	Stem Cell Transplantation 01/2010
1	Cell Transplantation 01/2010